Human IGFBP-3 Antibody Summary
Gly28-Lys291
Accession # CAA46087
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
IGFBP‑3 in Human Colon. IGFBP‑3 was detected in immersion fixed paraffin-embedded sections of human colon using 10 µg/mL Human IGFBP‑3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF675) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
IGFBP‑3 Inhibition of IGF‑II-dependent Cell Proliferation and Neutralization by Human IGFBP‑3 Antibody. Recombinant Human IGFBP‑3 (Catalog # 675-B3) inhibits Recombinant Human IGF‑II (Catalog # 292-G2) induced proliferation in the MCF‑7 human breast cancer cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IGF‑II (14 ng/mL) activity elicited by Recombinant Human IGFBP‑3 (0.2 µg/mL) is neutralized (green line) by increasing concentrations of Human IGFBP‑3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF675). The ND50 is typically 0.75-3.0 µg/mL.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IGFBP-3
The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBPs, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF.
Human IGFBP-3 cDNA encodes a 291 amino acid (aa) residue precursor protein with a putative 27 aa residue signal peptide that is processed to generate the 264 aa residue mature protein with three potential N-linked and two potential O-linked glycosylation sites. Human IGFBP-3 is expressed in multiple tissues. The highest expression level is found in the non-paranchymal cells of the liver. Expression levels are also higher during extrauterine life and peak during puberty. Human IGFBP-3 is the major IGF binding protein in plasma where it exists in a ternary complex with IGF-I or IGF-II and the acid-labile subunit (ALS).
- Jones, J.I. and D.R. Clemmons (1995) Endocrine Rev. 16:3.
- Kelley, K.M. et al. (1996) Int. J. Biochem. Cell Biol. 28:619.
- Spagnoli, A. and R.G. Rosenfeld (1997) Curr. Op. Endocrinology and Diabetes 4:1.
Product Datasheets
Citations for Human IGFBP-3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
13
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion
Authors: Zhao, L;Wang, Y;Mu, P;Zhang, X;Qi, R;Zhang, Y;Zhang, H;Zhu, X;Dong, Z;Dong, Y;
Cancer cell international
Species: Mouse, Human
Sample Types: Cell Lysates, Whole Cells, Whole Tissue
Applications: Western Blot, IHC -
Potent antitumor effects of the conditioned medium of bone marrow‐derived mesenchymal stem cells via IGFBP‐4
Authors: Yuma Furusaka, Shinya Inoue, Izuru Mizoguchi, Hideaki Hasegawa, Yasuhiro Katahira, Aruma Watanabe et al.
Cancer Science
-
Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system
Authors: A Weigert, X Zheng, A Nenzel, K Turkowski, S Günther, E Strack, E Sirait-Fis, E Elwakeel, IM Kur, VS Nikam, C Valasaraja, H Winter, A Wissgott, R Voswinkel, F Grimminger, B Brüne, W Seeger, SS Pullamsett, R Savai
Nature Communications, 2022-10-14;13(1):6078.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Netazepide Inhibits Expression of Pappalysin 2 in Type-1 Gastric Neuroendocrine Tumors
Authors: KA Lloyd, BN Parsons, MD Burkitt, AR Moore, S Papoutsopo, M Boyce, CA Duckworth, K Exarchou, N Howes, L Rainbow, Y Fang, C Oxvig, S Dodd, A Varro, N Hall, DM Pritchard
Cell Mol Gastroenterol Hepatol, 2020-01-28;0(0):.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Western Blot -
ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model
Authors: Q Xiang, Y Liao, H Chao, W Huang, J Liu, H Chen, D Hong, Z Zou, AP Xiang, W Li
Stem Cell Res Ther, 2018-02-26;9(1):51.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Neutralization -
Amyloid beta-mediated epigenetic alteration of insulin-like growth factor binding protein 3 controls cell survival in Alzheimer's disease.
Authors: Sung H, Choi E, Lyu D, Mook-Jung I, Ahn J
PLoS ONE, 2014-06-25;9(6):e99047.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.
Authors: Musil, J, Kutinova, L, Zurkova, K, Hainz, P, Babiarova, K, Krystofova, J, Nemeckova, S
Cancer Gene Ther, 2014-02-21;21(3):115-25.
Species: Mouse, Primate - Chlorocebus aethiops (African Green Monkey)
Sample Types: Whole Cells
Applications: Neutralization -
The contributions of HIF-target genes to tumor growth in RCC.
Authors: Zhang, Ting, Niu, Xiaohua, Liao, Lili, Cho, Eun-Ah, Yang, Haifeng
PLoS ONE, 2013-11-18;8(11):e80544.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Authors: Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H
Oncogene, 2011-07-04;31(6):776-86.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
IGFBP-3 is a metastasis suppression gene in prostate cancer.
Authors: Mehta HH, Gao Q, Galet C
Cancer Res., 2011-06-22;71(15):5154-63.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Human IGF Binding Protein-3 Overexpression Impairs Glucose Regulation in Mice via an Inhibition of Insulin Secretion.
Authors: Nguyen KH, Yao XH, Moulik S, Mishra S, Nyomba BL
Endocrinology, 2011-03-29;152(6):2184-96.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-P -
Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis.
Authors: Tyan SW, Kuo WH, Huang CK
PLoS ONE, 2011-01-13;6(1):e15313.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Neutralization, Western Blot -
The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori.
Authors: McCaig C, Duval C, Hemers E, Steele I, Pritchard DM, Przemeck S, Dimaline R, Ahmed S, Bodger K, Kerrigan DD, Wang TC, Dockray GJ, Varro A
Gastroenterology, 2006-03-06;130(6):1754-63.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human IGFBP-3 Antibody
There are currently no reviews for this product. Be the first to review Human IGFBP-3 Antibody and earn rewards!
Have you used Human IGFBP-3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image